Success Metrics

Clinical Success Rate

100.0%

Based on 6 completed trials

Completion Rate

100%(6/6)

Active Trials

0(0%)

Results Posted

67%(4 trials)

Phase Distribution

Ph phase_1

33%

Ph phase_2

17%

Ph phase_3

50%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 1Safety & dosage

2(33.3%)

Phase 2Efficacy & side effects

1(16.7%)

Phase 3Large-scale testing

3(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(6)

Detailed Status

Completed6

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 12 (33.3%)

Phase 21 (16.7%)

Phase 33 (50.0%)

Trials by Status

completed6100%

Recent Activity

0 active trials

Showing 5 of 6

completedphase_3

Clinical Trials (6)

Showing 6 of 6 trials

NCT02667444Phase 3

P3 Study Comparing Once Daily SB204 and Vehicle Gel in Acne

Completed

NCT02672332Phase 3

P3 Study in Acne Comparing Once Daily SB204 and Vehicle

Completed

NCT02242760Phase 2

P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris

Completed

NCT02798120Phase 3

P3 Long Term Safety Study of Once Daily SB204 in Acne

Completed

NCT02581072Phase 1

A Thorough ECG Study in Subjects With Acne Vulgaris Treated With SB204

Completed

NCT02801903Phase 1

Pharmacokinetics of Topical SB204 in Adolescents With Acne Vulgaris

Completed

All 6 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 6